Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile

MLA

Ting Wang, et al. “Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile.” Frontiers in Pharmacology, vol. 13, July 2022. EBSCOhost, https://doi.org/10.3389/fphar.2022.948161.

APA

Ting Wang, Neil McAuslane, Wim G. Goettsch, Hubert G. M. Leufkens, & Marie L. De Bruin. (2022). Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.948161

Chicago

Ting Wang, Neil McAuslane, Wim G. Goettsch, Hubert G. M. Leufkens, and Marie L. De Bruin. 2022. “Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile.” Frontiers in Pharmacology 13 (July). doi:10.3389/fphar.2022.948161.